Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
about
Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic CancerThe role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancerMolecular profiles of hereditary epithelial ovarian cancers and their implications for the biology of this disease.Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastomaOvarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalitiesConditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.Gross genomic alterations and gene expression profiles of high- grade serous carcinoma of the ovary with and without BRCA1 inactivation.DNA methylation profiles in ovarian cancer: implication in diagnosis and therapy (Review)Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.Nitric oxide: perspectives and emerging studies of a well known cytotoxinMolecular analysis of WWOX expression correlation with proliferation and apoptosis in glioblastoma multiformeConditional knockout of brca1/2 and p53 in mouse ovarian surface epithelium: do they play a role in ovarian carcinogenesis?RAD51C--a new human cancer susceptibility gene for sporadic squamous cell carcinoma of the head and neck (HNSCC).Potential markers for detection and monitoring of ovarian cancer.A seven-gene CpG-island methylation panel predicts breast cancer progressionEpigenomics and ovarian carcinoma.Caspase activity is downregulated in choriocarcinoma: a cDNA array differential expression study.Promoter hypermethylation of multiple genes in hydatidiform mole and choriocarcinoma.Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinoma.BRCA1 deficiency in ovarian cancer is associated with alteration in expression of several key regulators of cell motility - A proteomics study.The F-box protein FBXO44 mediates BRCA1 ubiquitination and degradation.Overexpression of NANOG in gestational trophoblastic diseases: effect on apoptosis, cell invasion, and clinical outcome.Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significanceFunctional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women.BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different.Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer.
P2860
Q21129296-37F48DE5-2DF0-45ED-A815-BFC66601AD81Q24791520-FE1A0B23-FD82-4DA1-8A00-87686C1B79EBQ30448232-56A50A91-ED13-40D1-9772-D7F9044D0CF2Q30781403-50827A73-71F1-4804-9BD4-B4FE9DE2FD89Q33315604-5F1E32C4-A18F-4ADA-B19B-C7EB03ACC9D1Q33521701-0F1593A1-F072-40E3-8F16-C5D2012FE6CBQ33521710-8FDCD66B-C8ED-4DF3-AD51-8DF2ECBC44ADQ33693203-014A7A4F-D9AE-468D-867E-69F697184955Q33799002-88DF4AB3-74C1-4CCF-8031-DC9D1153AFFBQ34049234-3FDCB9DF-3E19-4953-B72F-8CC7E2D1EB97Q34061919-7F334F45-11C6-4A72-855A-F688056ABCCBQ34376564-1095AEEA-7277-460F-9FA1-A2CEB70FA9BEQ34389214-9E3DB516-927A-42CC-937B-5E95E952F4BBQ34502557-9F560F26-DE05-4282-90BF-5644F60BB71DQ34960174-EFA3EA3D-505D-4D79-94F7-624CAFA4C73DQ35626799-E3F803A4-9E36-4362-B6B9-6DBD1AD18873Q35636575-0095335F-6592-4948-898F-4056BF610359Q35769689-BB60E2D6-AC93-4F98-85E5-F954E71FCF38Q35789796-D5D5056A-813D-41B0-ACE4-3336AC900D9AQ35789850-E6875D04-733B-425A-953E-206A5EFDACEDQ36189172-8BBAA3A8-DBC4-4293-B764-41A972A2E09EQ36436025-15CAD4DB-AA2A-4DCB-8475-D0C94F669F2EQ36891566-E3EDF42B-5B71-45E3-A0E6-F6DF98F92193Q37117082-5A15F37B-13F6-41A2-8371-B4DB53588D75Q37436858-8B8BC40E-7E72-4961-B9B7-C3F8A144F482Q37605747-DAC9BDE0-8D03-43BE-BBFF-E6D7A54567C5Q49875019-F5F0B292-2DF5-4044-80CE-2FB136C81756
P2860
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@ast
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@en
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@nl
type
label
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@ast
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@en
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@nl
prefLabel
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@ast
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@en
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
@nl
P2093
P1433
P1476
Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer
@en
P2093
Annie N Y Cheung
Hextan Y S Ngan
Hilmi Ozçelik
Kelvin Y K Chan
Ui-Soon Khoo
P304
P407
P577
2002-07-01T00:00:00Z